Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series

Unresectable cholangiocarcinoma is poorly responded to chemotherapy, especially for the case refractory to gemcitabine and cisplatin. Here, we tested whether high expression of thymidine phosphorylase (TP) can be a predictive biomarker for the indicator for gemcitabine and doxifluridine combination...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Kang, Myoung Hee, Lee, Won Sup, Go, Se-Il, Kim, Moon Jin, Lee, Un Seok, Choi, Hye Jung, Kim, Dong Chul, Lee, Jeong-Hee, Kim, Hoon-Gu, Bae, Kyung Soo, Cho, Jae Min
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2014
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4603134/
https://ncbi.nlm.nih.gov/pubmed/25526478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000305
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados